DiabetOmics, Inc. is a global medical diagnostics company pioneering innovative biochemical markers for the detection and monitoring of diabetes and complications related to diabetes. DiabetOmics also offers testing for the detection and monitoring of women with gestational diabetes and preeclampsia using a panel of markers that incorporates our unique patented biomarker glycosylated fibronectin.